Invixium raises $3M to address new demand for touchless biometrics with temperature screening
The round was participated in by Export Development Canada (EDC) and existing investors McRock Capital, BDC Capital and Connecticut Innovations. EDC’s investment came as part of the government agency’s newly-launched investment matching program, which was launched on a trial basis in April to provide liquidity to businesses during the fallout from COVID-19. Invixium is one of the first companies to receive funds under the program, which aims to match up to $5 million in venture capital, private equity and corporate investments to small and medium-sized enterprises that export products.
The company plans to use the funds to expand its sales and marketing efforts.
Invixium launched fever detection capabilities to its flagship TITAN terminal suite, and software to make operations with the IXM TITAN TOUCH 2 completely touchless a month ago. The terminals, along with the IXM WEB software, make up a complete solution for employee, visitor and individual screening, allowing a customized response when a fever is detected, such as denial of access or a push notification to site personnel, the company says.
“Screening of individuals at entry points to ensure workplace health and safety is the new norm,” states Invixium Founder and CEO Shiraz Kapadia. “We plan to lead the market with our touchless biometric solutions for workforce management and worksite access control and will continue to add innovative features like temperature detection to our solution as a COVID-19 response. I am honoured to have the backing of a prestigious group of investors who believe in our vision, company and technology.”